SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Soleno Therapeutics, Inc. Warrants (SLNOW)

SLNOW RSS Feed
Add SLNOW Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 6/6/2017 2:19:22 PM - Followers: 0 - Board type: Free - Posts Today: 0

Soleno Therapeutics, Inc. 1235 Radio Road Suite 110 Redwood City, CA 94065 United States 650-213-8444 http://www.soleno.life Soleno Therapeutics, Inc. focuses on the development and commercialization of nvel therapeutics for the treatment of rare diseases. The company’s lead candidate, diazoxide choline controlled-release (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is entering into Phase II/III clinical development. It also markets medical devices, including the CoSense End-Tidal Carbon Monoxide (ETCO) monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns; and NeoPip T-piece resuscitator and related consumables, which deliver consistent pre-set inspiratory pressure and positive end-expiratory pressures, as well as temperature probes, scales, surgical tables, and patient surfaces. In addition, the company offers Serenz, a handheld device that delivers non-inhaled carbon dioxide topically to the nasal mucosa. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. May 2017. Soleno Therapeutics, Inc. was founded in 1999 and is headquartered in Redwood City, California.
SLNOW
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
This board has been closed to posting. An alternative board can be found here:
Soleno Therapeutics, Inc.
PostSubject
#1   SLNOW buy 0.2447 stocktrademan 06/06/17 02:19:22 PM
PostSubject